EyePoint EYPT
NASDAQ EYPT
$4.58 +0.01 (+0.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

EyePoint (EYPT) Other Working Capital Changes (2018 - 2025)

EyePoint (EYPT) posted Other Working Capital Changes of -$6000.0 for Q1 2026, up 14.29% sequentially from -$7000.0 in Q4 2025, and up 99.97% YoY from -$3000.4 in Q1 2025.

Analysis

EyePoint (EYPT) Other Working Capital Changes (2018 - 2025) Analysis & Trends

EyePoint has reported Other Working Capital Changes for 9 years, with the latest figure at -$6000.0 in Q1 2026.

  • Quarterly Other Working Capital Changes rose 99.97% year-over-year to -$6000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.5 million (up 151.76% YoY) and the FY2025 annual result came in at -$33000.0, up 99.89% from the prior year.
  • Other Working Capital Changes improved to -$6000.0 in Q1 2026 per EYPT's latest filing, from -$7000.0 in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $495000.0 in Q4 2017 and troughed at -$1.1 million in Q1 2014.
  • A 5-year average of -$93222.2 and a median of -$9500.0 in 2015 frame the typical range for Other Working Capital Changes.
  • The widest YoY moves for Other Working Capital Changes: up 36260.61% in 2023, down 6191.22% in 2023.
  • Over 5 years, Other Working Capital Changes stood at -$205000.0 in 2022, then sank by 6191.22% to -$12.9 million in 2023, then plunged by 137.62% to -$30.6 million in 2024, then jumped by 99.98% to -$7000.0 in 2025, then increased by 14.29% to -$6000.0 in 2026.
  • According to Business Quant data, Other Working Capital Changes over the past three periods registered -$6000.0, -$7000.0, and -$8000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 EyePoint 398.53 Mn 218.06 Mn 507,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -5.12 Mn
Jun 30, 2025 -5.12 Mn
Mar 31, 2025 -23.52 Mn
Mar 31, 2025 -23.52 Mn
Dec 31, 2024 -8.59 Mn
Dec 31, 2024 -8.59 Mn
Sep 30, 2024 -7.78 Mn
Sep 30, 2024 -7.78 Mn
Jun 30, 2024 -5.47 Mn
Jun 30, 2024 -5.47 Mn
Mar 31, 2024 -8.80 Mn
Mar 31, 2024 -8.80 Mn
Dec 31, 2023 -12.90 Mn
Dec 31, 2023 -12.90 Mn
Sep 30, 2023 -13.92 Mn
Sep 30, 2023 -13.92 Mn
Jun 30, 2023 71.60 Mn
Jun 30, 2023 71.60 Mn
Mar 31, 2023 -255,000.00
Mar 31, 2023 -255,000.00